TrialThe pharmacogenomics journal2007

Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment.

P Molero et al.PubMed ↗Publisher ↗

No numbers read from the abstract.